ORYX seeks to establish enduring partnerships with experienced pharmaceutical companies for the following projects: ParvOryx, VicOryx, MicOryx.
The aim is to eventually out-license each one of these projects.
Please feel free to contact our Chief Business Development Officer.
Dr. Dr. Sven Rohmann
Phone: +49-8106-21 311-0
Mobile: +41-7957 78895
Fax: +49-8106-21 311-66